Intervention

intensity-modulated radiation therapy

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 15 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials15
Recruiting0
Common conditions25
Lead sponsors shown13
Advertisement

Clinical trials

15 shown
Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast CancerNCT02186470 · 2016-04-29
COMPLETED
Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryNCT01411098 · 2011-10-01
TERMINATED
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast CancerNCT01407770 · 2011-09-20
COMPLETED
Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung MetastasesNCT01586104 · 2011-02-01
COMPLETED
Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After SurgeryNCT01079793 · 2010-05-26
WITHDRAWN
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17NCT00951535 · 2009-07-20
ACTIVE_NOT_RECRUITING
MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the ProstateNCT01028885 · 2009-06-01
COMPLETED
Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)NCT00967863 · 2008-10-01
ACTIVE_NOT_RECRUITING
Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast CancerNCT00743314 · 2008-09-01
COMPLETED
Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast CancerNCT00818051 · 2008-08-01
UNKNOWN
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate CancerNCT00714753 · 2008-08-01
COMPLETED
Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate CancerNCT00482807 · 2004-08-31
COMPLETED
High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate CancerNCT00243321 · 2003-02-01
COMPLETED
Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate CancerNCT00653757 · 2002-03-01
COMPLETED
Intensity-Modulated Radiation Therapy in Treating Patients With Prostate CancerNCT00946543 · 2000-03-01
UNKNOWN

Common conditions

Trial status mix

COMPLETED9
ACTIVE_NOT_RECRUITING2
UNKNOWN2
TERMINATED1
WITHDRAWN1

Phase mix

PHASE16
NA4
PHASE24
EARLY_PHASE11
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.